Patent Assignment
Reel/Frame 070262/0605
Assignment of Assignor's Interest
Recorded: 2025-02-19
Pages: 2
Assignor
N, JOHN J.
Executed: 2017-11-17
Assignee
SPITFIRE PHARMA, INC.
400 OYSTER POINT BLVD., SUITE 202, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties
(3)
Peptide Pharmaceuticals for Insulin Resistance
Application:
16/747,759 →
Publication:
US 2020/0277351
Peptide Pharmaceuticals for Insulin Resistance
Application:
18/943,440 →
Publication:
US 2025/0136656
Peptide Pharmaceuticals for Insulin Resistance
Application:
18/988,066 →
Publication:
US 2025/0313604
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 19, 2025
From: SPIRFIRE PHARMA, INC.
To: MEDERIS DIABETES LLC
Reel/Frame 070262/0648 →
Affidavit of Address Change
Feb 19, 2025
From: MEDERIS DIABETES, LLC
To: MEDERIS DIABETES LLC
Reel/Frame 070266/0875 →
Security Interest
May 14, 2025
From: ALTIMMUNE, INC.; SPITFIRE PHARMA, LLC
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 071108/0692 →